The FDA in early 2026 highlighted enforcement actions targeting non-approved GLP-1 active ingredients in compounded drugs, which underscores the quality-control concern
Blood work to track BPC-157 BPC-157 doesn't have a single direct biomarker, so tracking focuses on the inflammation it's meant to reduce and on safety: hs-CRP a sensitive inflammation marker
In naturally aged mice and in doxorubicin-treated mice, FOXO4-DRI treatment significantly improved physical fitness, restored fur density, improved renal function, and improved liver function effects attributed to the selective elimination of accumulated senescent cells
As a result, we are not permitted to present health claims or specify consumption methods
Patients are provided with a detailed explanation of the treatment process , including what to expect at each stage